225 related articles for article (PubMed ID: 12791240)
1. Recombinant bovine soluble CD14 reduces severity of experimental Escherichia coli mastitis in mice.
Lee JW; Paape MJ; Zhao X
Vet Res; 2003; 34(3):307-16. PubMed ID: 12791240
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of recombinant bovine CD14.
Wang Y; Zarlenga DS; Paape MJ; Dahl GE; Tomita GM
Vet Res; 2003; 34(4):413-21. PubMed ID: 12911858
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of LPS-binding protein in bovine blood and milk following bacterial lipopolysaccharide challenge.
Bannerman DD; Paape MJ; Hare WR; Sohn EJ
J Dairy Sci; 2003 Oct; 86(10):3128-37. PubMed ID: 14594231
[TBL] [Abstract][Full Text] [Related]
4. The bovine innate immune response during experimentally-induced Pseudomonas aeruginosa mastitis.
Bannerman DD; Chockalingam A; Paape MJ; Hope JC
Vet Immunol Immunopathol; 2005 Sep; 107(3-4):201-15. PubMed ID: 15970335
[TBL] [Abstract][Full Text] [Related]
5. Recombinant soluble CD14 reduces severity of intramammary infection by Escherichia coli.
Lee JW; Paape MJ; Elsasser TH; Zhao X
Infect Immun; 2003 Jul; 71(7):4034-9. PubMed ID: 12819092
[TBL] [Abstract][Full Text] [Related]
6. The production and characterization of anti-bovine CD14 monoclonal antibodies.
Sohn EJ; Paape MJ; Peters RR; Fetterer RH; Talbot NC; Bannerman DD
Vet Res; 2004; 35(5):597-608. PubMed ID: 15369662
[TBL] [Abstract][Full Text] [Related]
7. Elevated milk soluble CD14 in bovine mammary glands challenged with Escherichia coli lipopolysaccharide.
Lee JW; Paape MJ; Elsasser TH; Zhao X
J Dairy Sci; 2003 Jul; 86(7):2382-9. PubMed ID: 12906056
[TBL] [Abstract][Full Text] [Related]
8. Intramammary defense against infections induced by Escherichia coli in cows.
Paape MJ; Lilius EM; Wiitanen PA; Kontio MP; Miller RH
Am J Vet Res; 1996 Apr; 57(4):477-82. PubMed ID: 8712510
[TBL] [Abstract][Full Text] [Related]
9. Increase of Escherichia coli inoculum doses induces faster innate immune response in primiparous cows.
Vangroenweghe F; Rainard P; Paape M; Duchateau L; Burvenich C
J Dairy Sci; 2004 Dec; 87(12):4132-44. PubMed ID: 15545375
[TBL] [Abstract][Full Text] [Related]
10. Recombinant bovine soluble CD14 sensitizes the mammary gland to lipopolysaccharide.
Wang Y; Zarlenga DS; Paape MJ; Dahl GE
Vet Immunol Immunopathol; 2002 May; 86(1-2):115-24. PubMed ID: 11943334
[TBL] [Abstract][Full Text] [Related]
11. Enhanced host immune recognition of mastitis causing Escherchia coli in CD-14 transgenic mice.
Wall R; Powell A; Sohn E; Foster-Frey J; Bannerman D; Paape M
Anim Biotechnol; 2009; 20(1):1-14. PubMed ID: 19160083
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of CpG-DNA against mastitis induced by Escherichia coli infection in a rat model.
Zhu Y; Fan H; Miao J; Zou S
Vet J; 2008 Mar; 175(3):369-78. PubMed ID: 17408997
[TBL] [Abstract][Full Text] [Related]
13. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria.
Lamping N; Dettmer R; Schröder NW; Pfeil D; Hallatschek W; Burger R; Schumann RR
J Clin Invest; 1998 May; 101(10):2065-71. PubMed ID: 9593762
[TBL] [Abstract][Full Text] [Related]
14. CD14 plays no major role in shock induced by Staphylococcus aureus but down-regulates TNF-alpha production.
Haziot A; Hijiya N; Schultz K; Zhang F; Gangloff SC; Goyert SM
J Immunol; 1999 Apr; 162(8):4801-5. PubMed ID: 10202023
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 4 is needed to restrict the invasion of Escherichia coli P4 into mammary gland epithelial cells in a murine model of acute mastitis.
Gonen E; Vallon-Eberhard A; Elazar S; Harmelin A; Brenner O; Rosenshine I; Jung S; Shpigel NY
Cell Microbiol; 2007 Dec; 9(12):2826-38. PubMed ID: 17608742
[TBL] [Abstract][Full Text] [Related]
16. The molecular basis for therapeutic concepts utilizing CD14.
Stelter F; Bernheiden M; Menzel R; Witt S; Jack RS; Grunwald U; Fan X; Schütt C
Prog Clin Biol Res; 1998; 397():301-13. PubMed ID: 9575571
[TBL] [Abstract][Full Text] [Related]
17. CpG-ODN enhances mammary gland defense during mastitis induced by Escherichia coli infection in goats.
Zhu YM; Miao JF; Zhang YS; Li Z; Zou SX; Deng YE
Vet Immunol Immunopathol; 2007 Dec; 120(3-4):168-76. PubMed ID: 17869348
[TBL] [Abstract][Full Text] [Related]
18. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
Sauter KS; Brcic M; Franchini M; Jungi TW
Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of bovine lactoferrin in the treatment of cows with experimentally induced Escherichia coli mastitis.
Kutila T; Suojala L; Lehtolainen T; Saloniemi H; Kaartinen L; Tähti M; Seppälä K; Pyörälä S
J Vet Pharmacol Ther; 2004 Aug; 27(4):197-202. PubMed ID: 15305847
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages.
Kanno S; Shouji A; Tomizawa A; Hiura T; Osanai Y; Ujibe M; Obara Y; Nakahata N; Ishikawa M
Life Sci; 2006 Jan; 78(7):673-81. PubMed ID: 16137700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]